https://www.selleckchem.com/pr....oducts/dimethindene-
1%) (95% CI 26.4-57.8) (HR 0.50, 95% CI 0.26-0.98, two-sided P=0.036). However, no significant difference in the OS rates between patients who underwent tumor resection in the 2 groups of patients was found (HR 0.80, 95% CI 0.35-1.83, two-sided P=0.595). Major postoperative complications rates after the stage-2 hepatectomy were 54.1% in the ALPPS group and 20.0% in the TACE + PVE group (risk ratio 2.70, 95% CI 1.17-6.25, P=0.007). ALPPS resulted in significantly better intermediate-term OS outcomes, at the expenses of a sig
Like
Comment
Share
